European Academy of Neurology 12th Congress 2026

• Congress Title: 12th Congress of the European Academy of Neurology (EAN 2026)

• Organizer: European Academy of Neurology (EAN)

• Dates: June 27–30, 2026

• Overarching Theme: “Brains, Bytes & Beyond: Tech in Neurology”

• Description: The 12th Congress of the European Academy of Neurology (EAN 2026) is Europe’s premier neurology congress, bringing together clinicians, researchers, and healthcare professionals from around the world. Centered around the overarching theme “Brains, Bytes & Beyond: Tech in Neurology,” the program explores how computing, artificial intelligence, digital biomarkers, wearable technologies, neuroimaging innovations, and neurotechnology are transforming neurological diagnosis, prognosis, and patient care. The scientific and educational program features Presidential and Overarching Theme Symposia, Clinical Grand Rounds, Focused Workshops, Special Sessions, Teaching Courses, Hands-On Courses, Case-Based Workshops, Career Development Sessions, and Oral/ePoster Sessions across all major neurological subspecialties.

Learning Objectives

Upon completion of this educational activity, participants should be better able to:

• Integrate emerging digital health tools, artificial intelligence (AI), machine learning algorithms, and wearable neurotechnologies into clinical neurological diagnosis, monitoring, and decision-making.

• Apply updated European Academy of Neurology (EAN) clinical practice guidelines for the diagnosis and management of acute and chronic neurological disorders.

• Formulate evidence-based diagnostic and therapeutic strategies for cerebrovascular diseases, acute ischemic stroke, intracerebral hemorrhage, and post-stroke neurorehabilitation.

• Evaluate and manage neurodegenerative diseases—including Alzheimer’s disease, non-Alzheimer dementias, Parkinson’s disease, atypical parkinsonian syndromes, and amyotrophic lateral sclerosis (ALS)—using novel biomarkers and disease-modifying therapies.

• Optimize the clinical management of multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), MOG antibody-associated disease (MOGAD), and autoimmune encephalitides.

• Diagnose and treat paroxysmal neurological disorders, including epilepsy, status epilepticus, migraine, trigeminal autonomic cephalalgias, and sleep-wake disorders.

• Perform and interpret clinical neurophysiology, neuromuscular electrodiagnostics, neurosonology, and advanced neuroimaging in patients with peripheral neuropathies, myopathies, and neuromuscular junction disorders.

• Address complex multisystem neurological manifestations across neuro-oncology, neuro-infectious diseases, neurocritical care, neurogenetics, autonomic disorders, and palliative neurology.

Target Audience

The congress is an essential event for neurologists, neurology residents and trainees, neuroscientists, clinical neurophysiologists, allied health professionals, and practitioners seeking to stay at the forefront of neurological research, clinical practice, and continuing medical education.

Best for Neurologists, Vascular Neurologists (Stroke Specialists), Movement Disorder Specialists, Behavioral and Cognitive Neurologists, Neuroimmunologists, Epileptologists, Headache Specialists, Neuromuscular Medicine Specialists, Clinical Neurophysiologists, Neurocritical Care Physicians, Neuro-Oncologists, Pediatric Neurologists, Sleep Medicine Specialists, Neuro-Ophthalmologists, Neuro-Otologists, Neuroradiologists, Neurosurgeons, Medical Geneticists, Physical Medicine and Rehabilitation (PM&R) Specialists (Physiatrists), Geriatricians, Psychiatrists, Pain Management Specialists, Infectious Disease Specialists, and Palliative Care Specialists.

Topics

1. Overarching Theme Track: “Brains, Bytes & Beyond: Tech in Neurology”

• Artificial Intelligence (AI) and Machine Learning in Neurological Diagnostics and Prognostication

• Digital Biomarkers, Wearable Sensors, and Remote Patient Monitoring in Neurological Diseases

• Brain-Computer Interfaces (BCIs), Neuroprosthetics, and Closed-Loop Neuromodulation

• Big Data, Computational Neuroscience, and Precision Medicine in Neurology

• Telemedicine, Telestroke Networks, and Virtual Care Models in Clinical Practice

• Ethical, Legal, and Regulatory Challenges of AI and Emerging Neurotechnologies

2. Cerebrovascular Diseases & Stroke

• Hyperacute Management of Acute Ischemic Stroke: Intravenous Thrombolysis and Mechanical Thrombectomy

• Neuroimaging Selection in Extended Time Windows and Large Core Infarcts

• Intracerebral Hemorrhage (ICH) and Subarachnoid Hemorrhage: Acute Blood Pressure Control, Hemostatic Therapy, and Minimally Invasive Surgery

• Cerebral Small Vessel Disease, Vascular Cognitive Impairment, and Cerebral Amyloid Angiopathy

• Secondary Stroke Prevention: Antithrombotic Strategies, Patent Foramen Ovale (PFO) Closure, and Carotid Stenosis Management

• Stroke in Young Adults, Rare Causes of Stroke, and Cerebral Venous Sinus Thrombosis (CVST)

3. Movement Disorders

• Parkinson’s Disease: Prodromal Markers, Alpha-Synuclein Seed Amplification Assays, and Disease-Modifying Trials

• Device-Aided Therapies in Advanced Parkinson’s Disease: Adaptive Deep Brain Stimulation (aDBS), Focused Ultrasound, and Continuous Subcutaneous Infusions

• Atypical Parkinsonian Syndromes: Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), and Corticobasal Degeneration (CBD)

• Hyperkinetic Movement Disorders: Essential Tremor, Dystonia, Huntington’s Disease, Chorea, Myoclonus, and Tics

• Functional Movement Disorders: Positive Diagnostic Signs and Multidisciplinary Rehabilitation

4. Dementia, Cognitive & Behavioral Neurology

• Alzheimer’s Disease in the Era of Anti-Amyloid Immunotherapies: Patient Selection, APOE Genotyping, and ARIA Monitoring

• Fluid (Plasma and CSF) and PET Biomarkers for Early Detection of Neurodegeneration

• Frontotemporal Lobar Degeneration (FTLD), Primary Progressive Aphasias, and Dementia with Lewy Bodies (DLB)

• Normal Pressure Hydrocephalus (NPH) and Reversible Causes of Cognitive Decline

• Management of Neuropsychiatric Symptoms and Behavioral Disturbances in Dementia

5. Multiple Sclerosis & Neuroimmunology

• Evolving Diagnostic Criteria (McDonald Criteria Updates) and Early High-Efficacy Treatment in Multiple Sclerosis

• Smoldering MS, Progression Independent of Relapse Activity (PIRA), and BTK Inhibitors

• Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody-Associated Disease (MOGAD): Diagnostic Pitfalls and Targeted Biologics

• Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes

• Neurosarcoidosis, CNS Vasculitis, and Neurological Complications of Immune Checkpoint Inhibitors

6. Epilepsy & Clinical Neurophysiology

• Classification and Medical Management of Focal, Generalized, and Developmental and Epileptic Encephalopathies (DEEs)

• First Seizure Evaluation, Seizure Mimics, and Psychogenic Non-Epileptic Seizures (PNES)

• Diagnosis and Protocol-Driven Management of Refractory and Super-Refractory Status Epilepticus

• Presurgical Evaluation, Stereo-EEG (sEEG), Epilepsy Surgery, and Neurostimulation (VNS, RNS, DBS)

• Women with Epilepsy: Teratogenicity, Contraception, and Antiseizure Medication Management in Pregnancy

• Quantitative EEG, Automated Seizure Detection, and Long-Term Video-EEG Monitoring

7. Headache & Pain Disorders

• Pathophysiology and Personalized Treatment of Migraine: CGRP Monoclonal Antibodies, Gepants, and Ditans

• Medication-Overuse Headache and Chronic Migraine Management Strategies

• Trigeminal Autonomic Cephalalgias (Cluster Headache, Paroxysmal Hemicrania, SUNCT/SUNA)

• Secondary Headache Red Flags, Idiopathic Intracranial Hypertension (IIH), and Spontaneous Intracranial Hypotension (SIH)

• Trigeminal Neuralgia, Cranial Neuralgias, and Central/Peripheral Neuropathic Pain Syndromes

8. Neuromuscular Disorders, Muscle & NMJ Diseases

• Amyotrophic Lateral Sclerosis (ALS) and Motor Neuron Diseases: Genetic Testing, Antisense Oligonucleotides, and Multidisciplinary Care

• Immune-Mediated Neuropathies: Guillain-Barré Syndrome (GBS), CIDP, and Autoimmune Nodopathies

• Hereditary Neuropathies (Charcot-Marie-Tooth Disease) and Transthyretin Familial Amyloid Polyneuropathy (hATTR-PN)

• Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: FcRn Antagonists and Complement Inhibitors

• Inherited Myopathies, Muscular Dystrophies, Channelopathies, and Idiopathic Inflammatory Myopathies (Dermatomyositis, Antisynthetase Syndrome, IMNM, IBM)

9. Sleep-Wake Disorders

• REM Sleep Behavior Disorder (RBD) as a Prodrome of Synucleinopathies

• Narcolepsy and Central Disorders of Hypersomnolence: Orexin Agonists and Current Pharmacotherapy

• Restless Legs Syndrome (RLS), Periodic Limb Movement Disorder, and Circadian Rhythm Sleep-Wake Disorders

• Sleep-Related Breathing Disorders and Nocturnal Epilepsy

10. Neurocritical Care, Coma & Disorders of Consciousness

• Multimodal Neuromonitoring and Management of Intracranial Hypertension and Traumatic Brain Injury (TBI)

• Diagnosis, Prognostication, and Neurorehabilitation of Coma and Prolonged Disorders of Consciousness (UWS, MCS, Cognitive Motor Dissociation)

• Neurological Prognostication After Cardiac Arrest and Hypoxic-Ischemic Brain Injury

• Determination of Brain Death / Death by Neurologic Criteria (DNC)

11. Neuro-Oncology, Neuro-Infectious Diseases & Neurogenetics

• Molecular Classification and Targeted Therapy of Gliomas, CNS Lymphomas, and Brain Metastases

• Neurological Complications of Systemic Cancer, CAR-T Cell Therapy (ICANS), and Radiation Necrosis

• Acute Bacterial, Viral, Fungal, and Tuberculous Meningitis and Encephalitis

• Neuroborreliosis, Neurosyphilis, HIV-Associated Neurocognitive Disorders, and Emerging Neurotropic Infections

• Next-Generation Sequencing (NGS), Repeat Expansion Disorders, Hereditary Spastic Paraplegias, Spinocerebellar Ataxias, and Gene Therapies in Neurology

12. Autonomic Nervous System, Neuro-Ophthalmology, Neuro-Otology & Neurorehabilitation

• Evaluation and Management of Neurogenic Orthostatic Hypotension, Postural Orthostatic Tachycardia Syndrome (POTS), and Autonomic Failure

• Acute Vestibular Syndrome, Episodic Vertigo (BPPV, Vestibular Migraine, Meniere’s Disease), and Eye Movement Disorders

• Optic Neuritis, Ischemic Optic Neuropathies, and Diplopia Workup

• Robotics, Non-Invasive Brain Stimulation (TMS, tDCS), Virtual Reality, and Spasticity Management in Neurorehabilitation

• Palliative Care, Advance Care Planning, and End-of-Life Decision-Making in Severe Neurological Illness